Search

Laos-based pharmaceutical company BioSpring completes phase 1 of manufacturing facility

BioSpring is a vertically integrated pharmaceutical company providing innovative solutions from formulation development to product commercialization.


BioSpring (“BioSpring Group.LTD” “BioSpring Group”) announces Phase 1 of the manufacturing unit was constructed and delivered.


This time, the delivery of the manufacturing unit constructed according to the ICH(1)-GMP(2) standard is the first step for BioSpring to serve global users.


At present, new therapies and new drugs are still emerging in advanced countries. At the same time, unmet medical needs still exist in developing countries.”

— Sinapha xong,Chairman of BioSpring


With the strong support and joint efforts of the Vientiane government of Laos and the Saisetta Comprehensive Development Zone, the first phase of the BioSpring manufacturing unit was officially delivered. Next, BioSpring will focus on the development of precision therapy, antiviral products, and consumer brands. As one of the emerging pharmaceutical companies in Laos, BioSpring will make full use of the strategic opportunity period given by WTO to LDC(3) member TRIPS(4).


About BioSpring BioSpring is a vertically integrated pharmaceutical company providing innovative solutions from formulation development to product commercialization. We aspire to lead by example and be a business that serves users around the world, and we will launch a range of affordable products that can be used globally.

Visit:www.biospring.ltd to know more information.


Source: Biospring Ltd.